Skip to Content

Adaptive Biotechnologies

ADPT

Buy $ADPT at eToro
Rank 2539
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 1551 EASTLAKE AVENUE EAST SUITE 200, SEATTLE, WA, US

Adaptive Biotechnologies - Key figures

Market cap 1.22 Billion
Revenue 154.52 Million
Profit 90.98 Million
P/E Ratio No information
P/s Ratio 7.92
Buy $ADPT at eToro

Adaptive Biotechnologies - Description

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

The company is headquartered in Seattle, Washington.